{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:44:11Z","timestamp":1791582251782,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060644"],"award-info":[{"award-number":["82060644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejpb.2024.114536","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T16:33:37Z","timestamp":1729528417000},"page":"114536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Study on the crystallinity of PEG on the crystalline size of flavonoids in a crystalline dispersion system"],"prefix":"10.1016","volume":"205","author":[{"given":"Hua","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5582-2900","authenticated-orcid":false,"given":"Chunhui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114536_b0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cbdd.14152","article-title":"Gossypin: a flavonoid with diverse pharmacological effects","volume":"101","author":"Song","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejpb.2024.114536_b0010","doi-asserted-by":"crossref","first-page":"1168990","DOI":"10.3389\/fphar.2023.1168990","article-title":"Natural flavones from edible and medicinal plants exhibit enormous potential to treat ulcerative colitis","volume":"14","author":"Lu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114536_b0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/1871527317666181105093834","article-title":"A pharmacological appraisal of neuroprotective and neurorestorative flavonoids against neurodegenerative diseases","volume":"18","author":"Zhao","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ejpb.2024.114536_b0020","first-page":"658","article-title":"Flavonoids for the treatment of breast cancer, present status and future prospective, anti cancer agents","volume":"23","author":"Sahoo","year":"2023","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejpb.2024.114536_b0025","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/162750","article-title":"Chemistry and biological activities of flavonoids: an overview","volume":"2013","author":"Kumar","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.ejpb.2024.114536_b0030","doi-asserted-by":"crossref","first-page":"14950","DOI":"10.3390\/ijms140714950","article-title":"Plant flavonoids\u2013biosynthesis, transport and involvement in stress responses","volume":"14","author":"Petrussa","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2024.114536_b0035","first-page":"783","article-title":"Flavonoid delivery by solid dispersion: a systematic review","volume":"21","author":"Colombo","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejpb.2024.114536_b0040","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1208\/s12249-016-0647-3","article-title":"Extensive diminution of particle size and amorphization of a crystalline drug attained by eminent technology of solid dispersion: a comparative study","volume":"18","author":"Singh","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2024.114536_b0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejpb.2017.12.016","article-title":"Oral bioavailability enhancement of \u03b2-lapachone, a poorly soluble fast crystallizer, by cocrystal, amorphous solid dispersion, and crystalline solid dispersion","volume":"124","author":"Liu","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114536_b0050","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1208\/s12249-020-01802-0","article-title":"Characterizing and exploring the differences in dissolution and stability between crystalline solid dispersion and amorphous solid dispersion","volume":"21","author":"Wang","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2024.114536_b0055","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s13346-023-01348-1","article-title":"Study on the regulation mechanism of effective glass transition temperature on the crystallization of crystalline solid dispersion","volume":"13","author":"Zhang","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2024.114536_b0060","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.3390\/pharmaceutics15102493","article-title":"Influence of intermolecular interactions on crystallite size in crystalline solid dispersions","volume":"15","author":"Huang","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2024.114536_b0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2023.07.031","article-title":"Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery","volume":"361","author":"Berger","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114536_b0070","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1080\/17425247.2016.1198769","article-title":"The role of the carrier in the formulation of pharmaceutical solid dispersions. Part II: amorphous carriers","volume":"13","author":"Van Duong","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114536_b0075","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1021\/acsomega.9b04075","article-title":"Enhanced dissolution of luteolin by solid dispersion prepared by different methods: physicochemical characterization and antioxidant activity","volume":"5","author":"Alshehri","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejpb.2024.114536_b0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ejps.2012.12.012","article-title":"Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation","volume":"48","author":"Sarode","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114536_b0085","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13346-023-01400-0","article-title":"Evaluation of microstructure, dissolution rate, and oral bioavailability of paclitaxel poloxamer 188 solid dispersion","volume":"14","author":"Liu","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejpb.2024.114536_b0090","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3390\/ph16121640","article-title":"Influence mechanism of drug-polymer compatibility on humidity stability of crystalline solid dispersion","volume":"16","author":"Hu","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2024.114536_b0095","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1021\/acs.cgd.6b00879","article-title":"Dissolution Characteristics of Fast-Crystallizing \u03b2-Lapachone within Different Semicrystalline Microstructures of Polyethylene Glycol or Poly (ethylene oxide)\u2013Poly (propylene oxide)\u2013Poly (ethylene oxide) Triblock Copolymer","volume":"16","author":"Chen","year":"2016","journal-title":"Cryst. Growth Des."},{"key":"10.1016\/j.ejpb.2024.114536_b0100","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.apsb.2021.02.015","article-title":"The contribution of absorption of integral nanocrystals to enhancement of oral bioavailability of quercetin","volume":"11","author":"Shen","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejpb.2024.114536_b0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/03639045.2020.1862173","article-title":"Surfactant-free amorphous solid dispersion with high dissolution for bioavailability enhancement of hydrophobic drugs: a case of quercetin","volume":"47","author":"Han","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2024.114536_b0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejps.2015.02.003","article-title":"Investigation and correlation of drug polymer miscibility and molecular interactions by various approaches for the preparation of amorphous solid dispersions","volume":"71","author":"Meng","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114536_b0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/jphp.12141","article-title":"Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying","volume":"66","author":"Tian","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114536_b0120","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.carbpol.2016.09.067","article-title":"Novel cellulose-based amorphous solid dispersions enhance quercetin solution concentrations in vitro","volume":"157","author":"Gilley","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2024.114536_b0125","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/jps.23583","article-title":"Prediction of drug-polymer miscibility through the use of solubility parameter based Flory-Huggins interaction parameter and the experimental validation: PEG as model polymer","volume":"102","author":"Thakral","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114536_b0130","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/polym15071758","article-title":"Effect of molecular weight on the dissolution profiles of PEG solid dispersions containing Ketoprofen","volume":"15","author":"Le Khanh","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.ejpb.2024.114536_b0135","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ptr.7397","article-title":"Chemistry, pharmacokinetics, pharmacological activities, and toxicity of Quercitrin","volume":"36","author":"Chen","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejpb.2024.114536_b0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0032-3861(66)90055-3","article-title":"Heat capacities of propylene oxide and of some polymers of ethylene and propylene oxides","volume":"7","author":"Beaumont","year":"1966","journal-title":"Polymer"},{"key":"10.1016\/j.ejpb.2024.114536_b0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0378-5173(86)90142-0","article-title":"The properties of solid dispersions of indomethacin or phenylbutazone in polyethylene glycol","volume":"28","author":"Ford","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114536_b0150","doi-asserted-by":"crossref","first-page":"4239207","DOI":"10.1155\/2020\/4239207","article-title":"Preparation and characterization of PEG4000 palmitate\/PEG8000 palmitate-solid dispersion containing the poorly water-soluble drug Andrographolide","volume":"2020","author":"Zeng","year":"2020","journal-title":"Adv. Polym. Tech."},{"key":"10.1016\/j.ejpb.2024.114536_b0155","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1080\/03639045.2019.1606822","article-title":"Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide","volume":"45","author":"Trivino","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2024.114536_b0160","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1021\/ma034695a","article-title":"Effect of hydrogen bonding strength on the microstructure and crystallization behavior of crystalline polymer blends","volume":"36","author":"Kuo","year":"2003","journal-title":"Macromolecules"},{"key":"10.1016\/j.ejpb.2024.114536_b0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2013.11.001","article-title":"Fundamental aspects of solid dispersion technology for poorly soluble drugs","volume":"4","author":"Huang","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejpb.2024.114536_b0170","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.1021\/ma960508f","article-title":"Microstructure of melt-miscible, semicrystalline polymer blends","volume":"29","author":"Talibuddin","year":"1996","journal-title":"Macromolecules"},{"key":"10.1016\/j.ejpb.2024.114536_b0175","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1021\/mp500661v","article-title":"Crystallization of bifonazole and acetaminophen within the matrix of semicrystalline, PEO-PPO-PEO triblock copolymers","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2024.114536_b0180","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1567201815666180924151458","article-title":"Improved in vivo effect of chrysin as an absorption enhancer via the preparation of ternary solid dispersion with Brij\u00aeL4 and aminoclay","volume":"16","author":"Lee","year":"2019","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114536_b0185","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijpharm.2018.02.036","article-title":"Aqueous injection of quercetin: an approach for confirmation of its direct in vivo cardiovascular effects","volume":"541","author":"Porcu","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114536_b0190","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1186\/s12879-022-07791-8","article-title":"Preparation, characterization, and in-vitro cytotoxicity of nanoliposomes loaded with anti-tubercular drugs and TGF-\u03b21 siRNA for improving spinal tuberculosis therapy","volume":"22","author":"Yang","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ejpb.2024.114536_b0195","doi-asserted-by":"crossref","DOI":"10.3390\/polym14173646","article-title":"Influence of cooling rate on crystallization behavior of semi-crystalline polypropylene: experiments and mathematical modeling","volume":"14","author":"Hu","year":"2022","journal-title":"Polymers (basel)"},{"key":"10.1016\/j.ejpb.2024.114536_b0200","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/mp5008647","article-title":"Oral bioavailability and pharmacodynamic activity of hesperetin nanocrystals generated using a novel bottom-up technology","volume":"12","author":"Shete","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2024.114536_b0205","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/jps.22748","article-title":"Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods","volume":"101","author":"Abu-Diak","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114536_b0210","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijpharm.2016.05.014","article-title":"The effect of PEG molecular weights on the thermal stability and dissolution behaviors of griseofulvin-PEG crystalline inclusion complexes","volume":"508","author":"Yang","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114536_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.polymer.2020.123370","article-title":"Confined crystallization of poly (ethylene glycol) in spherulites of poly (L-lactic acid) in a PLLA\/PEG blend","volume":"215","author":"Banpean","year":"2021","journal-title":"Polymer"},{"key":"10.1016\/j.ejpb.2024.114536_b0220","doi-asserted-by":"crossref","unstructured":"G. Ilevbare, P. Marsac, A.J.D. Mitra, d.m.w.o.d.-l. properties, Performance and characterization of amorphous solid dispersions: an overview, Discovering and Developing Molecules with Optimal Drug-Like Properties (2014) 287-343.","DOI":"10.1007\/978-1-4939-1399-2_10"},{"key":"10.1016\/j.ejpb.2024.114536_b0225","doi-asserted-by":"crossref","unstructured":"P.A. Meenan, S.R. Anderson, D.L.J.H.o.i.c. Klug, The influence of impurities and solvents on crystallization, Handbook of Industrial Crystallization (2002) 67-100.","DOI":"10.1016\/B978-075067012-8\/50005-7"},{"key":"10.1016\/j.ejpb.2024.114536_b0230","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1007\/s11095-009-9974-3","article-title":"Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions","volume":"26","author":"Rumondor","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2024.114536_b0235","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1021\/acs.molpharmaceut.3c00526","article-title":"Crystallinity: a complex critical quality attribute of amorphous solid dispersions","volume":"20","author":"Moseson","year":"2023","journal-title":"Mol. Pharm."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112400362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093964112400362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T23:33:05Z","timestamp":1733009585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093964112400362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"alternative-id":["S093964112400362X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114536","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study on the crystallinity of PEG on the crystalline size of flavonoids in a crystalline dispersion system","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114536"}}